Modern non-invasive diagnostics
We offer a health check with accurate molecular diagnostic tests developed by our specialists. The advanced technology used in our modern laboratory ensures the reliability of the tests.
About us
JSC Diagnolita, founded in 2013, develops molecular diagnostic technologies and tests and provides medical diagnostic services. We offer modern non-invasive tests for the diagnosis of oncological and infectious diseases. We want people to be able to use the latest scientific achievements to improve their health.
In our well-equipped modern laboratory, we separate different steps of the testing procedure and control possible pollution to ensure the quality of the entire process. We regularly participate in interlaboratory testing programs that confirm the accuracy and effectiveness of our tests.
A modern licensed laboratory
Our laboratory is accredited according to the recognized quality control standard LST EN ISO 15189:2023.
Highly qualified specialists
The laboratory employs highly qualified specialists who regularly deepen their knowledge, are interested in innovation, participate in international conferences, and conduct scientific research.
Scientific and biomedical research
9 years of experience in conducting scientific, biomedical research, development of new diagnostic methods and their validation.
Prostate cancer biomarker test
The test helps decide whether an invasive biopsy procedure is worth it. The answer includes the probability of a positive biopsy and significant cancer if a biopsy were performed.
Urine collected with a special tube after or without prostate massage is tested. Results are provided within 7 days from the receipt of the sample to the laboratory.
A prostate biopsy is an invasive test that takes tiny amounts of prostate tissue (less than 1% of the prostate volume). Cancer may go undiagnosed during a biopsy simply because the needle did not hit the tumor. The consequence of this is that half of the biopsies performed are negative. Also, a prostate biopsy can cause complications such as infections, sepsis, or hematuria.
COVID-19 PCR Test
Avoids the unpleasant procedure of taking a nasopharyngeal swab.
The possibility of performing the test at home with a video call or after arriving at the site by car.
A sensitive and specific test – PCR method is used.
Developed in Lithuania JSC Diagnolita laboratory;
All strains of the SARS-CoV-2 virus present in Lithuania are identified.
The laboratory employs highly qualified specialists who regularly deepen their knowledge, are interested in innovation, participate in international conferences, and conduct scientific research.
Genetic testing of hereditary breast and ovarian cancer
Non-invasive genetic testing for hereditary breast and ovarian cancer uses saliva or oral epithelial smear.
Test uses modern next-generation sequencing technology.
Sample is self-collected at home.
Choice of three different scopes of genetic testing: DiaBOCs BRCA, DiaBOCs HEPA, and DiaBOCs HEPA+.
Identifies mutations in the genes most associated with hereditary breast and ovarian cancer.
Working hours 
